Literature DB >> 321164

T lymphocytes bearing complement receptors in a patient with chronic lymphocytic leukaemia.

H R Toben, R G Smith.   

Abstract

A patient is described who presented with a disease clinically resembling chronic lymphocytic leukaemia, characterized by generalized lymphadenopathy, pleural and peritoneal effusions, a blood lymphocyte count of 700,000/mul and failure to respond to conventional therapy. At least 95% of these cells formed rosettes with sheep erythrocytes (E) and with erythrocytes coated with 19S antibodies and complement (EAC). All of these cells bound rabbit anti-human thymocyte serum; this serum bound to 0--22% of the lymphocytes from twenty other patients with chronic lymphocytic leukaemia. These unusual cells did not bear surface immunoglobulin detectable by immunofluorescence. The clinical and cellular features of this malignancy are compared to previously reported cases of T cell chronic lymphocytic leukaemia. As this case illustrates, T-cell chronic lymphocytic leukaemia may present without skin lesions and may be a more aggressive disease than the more common B-cell neoplasm.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 321164      PMCID: PMC1540779     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  47 in total

1.  Peripheral blood T- and B-lymphocytes in patients with lymphoma and acute leukemia.

Authors:  A H Chin; J H Saiki; J M Trujillo; R C Williams
Journal:  Clin Immunol Immunopathol       Date:  1973-07

2.  Letter: Chronic lymphocytic leukaemia of T-cell origin?

Authors:  M Sumiya; H Mizoguchi; K Kosaka; Y Miura; F Takaku; J I Yato
Journal:  Lancet       Date:  1973-10-20       Impact factor: 79.321

3.  Prolymphocytic leukaemia of B and T cell type.

Authors:  D Catovsky; J Galetto; A Okos; D A Galton; E Wiltshaw; G Stathopoulos
Journal:  Lancet       Date:  1973-08-04       Impact factor: 79.321

4.  Thymus-derived proliferating lymphocytes in chronic lymphocytic leukaemia.

Authors:  I Lille; A Desplaces; L Meeus; R T Saracino; J C Brouet
Journal:  Lancet       Date:  1973-08-04       Impact factor: 79.321

5.  Cell-surface immunoglobulins in chronic lymphocytic leukemia and allied disorders.

Authors:  A C Aisenberg; K J Bloch; J C Long
Journal:  Am J Med       Date:  1973-08       Impact factor: 4.965

6.  Isolation of normal T cells in chronic lymphatic leukaemia.

Authors:  J Wybran; S Chantler; H H Fudenberg
Journal:  Lancet       Date:  1973-01-20       Impact factor: 79.321

7.  Surface bound immunoglobulins as a cell marker in human lymphoproliferative diseases.

Authors:  J L Preud'homme; M Seligmann
Journal:  Blood       Date:  1972-12       Impact factor: 22.113

8.  Lymphocyte surface immunoglobulins. Distribution and frequency in lymphoproliferative diseases.

Authors:  W F Piessens; P H Schur; W C Moloney; W H Churchill
Journal:  N Engl J Med       Date:  1973-01-25       Impact factor: 91.245

9.  Interaction of aggregated -globulin with B lymphocytes.

Authors:  H B Dickler; H G Kunkel
Journal:  J Exp Med       Date:  1972-07-01       Impact factor: 14.307

10.  Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells.

Authors:  M Jondal; G Holm; H Wigzell
Journal:  J Exp Med       Date:  1972-08-01       Impact factor: 14.307

View more
  6 in total

1.  Evidence for the presence of a receptor for IgM on the pathological cells of Sézary's syndrome.

Authors:  C P Worman; G F Burns; C R Barker
Journal:  Clin Exp Immunol       Date:  1978-03       Impact factor: 4.330

2.  Fluctuations in the T and B characteristics of two cases of T-cell hairy-cell leukaemia.

Authors:  G F Burns; C P Worman; J C Cawley
Journal:  Clin Exp Immunol       Date:  1980-01       Impact factor: 4.330

3.  Impaired antibody responses to a pneumococcal polysaccharide vaccine in patients with non-Hodgkin's lymphoma in remission.

Authors:  O F Ballester; M Shurafa; H Toben; K S Kumar; C L Burek
Journal:  J Clin Immunol       Date:  1981-04       Impact factor: 8.317

4.  T-cell growth factor-mediated proliferation of lymphocytes from a T-chronic lymphocytic leukaemia patient lacking mitogen and alloantigen responsiveness.

Authors:  J E De Vries; F A Vyth; J Mendelsohn
Journal:  Clin Exp Immunol       Date:  1981-02       Impact factor: 4.330

5.  Infection of human thymocytes by Epstein-Barr virus.

Authors:  D Watry; J A Hedrick; S Siervo; G Rhodes; J J Lamberti; J D Lambris; C D Tsoukas
Journal:  J Exp Med       Date:  1991-04-01       Impact factor: 14.307

6.  Surface phenotyping, histology and the nature of non-Hodgkin lymphoma in 157 patients.

Authors:  J A Habeshaw; P F Catley; A G Stansfeld; R L Brearley
Journal:  Br J Cancer       Date:  1979-07       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.